2025-05-28 - Analysis Report
Okay, here's an analysis of Natera Inc. (NTRA) based on the provided data. The report is in English, includes key numbers, and incorporates analysis of each section.

**Natera Inc. (NTRA) Stock Analysis**

**0. Executive Summary:**

Natera Inc. (NTRA) is a diagnostics company specializing in genetic testing. Overall, recent performance shows mixed signals. While the stock has recently shown positive movement and long-term return expectations are high, historical volatility and negative profitability require caution. A hybrid signal suggests a reduction in holdings (70% cash).

**1. Performance Relative to S&P 500 (VOO):**

*   **Cumulative Return (NTRA):** 128.48%
*   **Cumulative Return (VOO):** 83.49%
*   **Absolute Difference:** 45.0%
*   **Relative Deviation:** 13.2% (Positioned at the 13.2 percentile within its historical deviation range.)

**Analysis:** NTRA has significantly outperformed the S&P 500 overall. However, the relative deviation indicates that the current outperformance is low compared to its historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta   | Cap(B) |
|------------|---------|---------|---------|--------|--------|
| 2015-2017  | -6.0%   | 62.4%   | -31.0%  | -0.0   | 1.2    |
| 2016-2018  | 29.0%   | 80.1%   | 11.0%   | 0.1    | 1.9    |
| 2017-2019  | 159.0%  | 80.1%   | 130.0%  | 1.2    | 4.6    |
| 2018-2020  | 530.0%  | 80.1%   | 505.0%  | 0.6    | 13.6   |
| 2019-2021  | 356.0%  | 62.9%   | 301.0%  | 0.2    | 12.8   |
| 2020-2022  | -119.0% | 62.9%   | -125.0% | 0.3    | 5.5    |
| 2021-2023  | -482.0% | 69.9%   | -499.0% | 1.2    | 8.6    |
| 2022-2024  | -75.0%  | 70.5%   | -92.0%  | 1.3    | 21.6   |
| 2023-2025  | 77.0%   | 72.8%   | 46.0%   | 0.9    | 21.5   |

*   **CAGR:** Highly variable, ranging from -482% to 530%, demonstrating significant volatility.
*   **MDD:** Consistently high Maximum Drawdown values, indicating significant risk.
*   **Alpha:** Highly variable and volatile, with a negative Alpha in recent years.
*   **Beta:** NTRA generally has a positive beta, indicating correlation with the market, but its value fluctuates, implying changing sensitivity to market movements.

**Analysis:** The Alpha and Beta analysis reveals the NTRA stock is volatile and high risk. While it can outperform the market (high positive alpha in some periods), it also experiences severe underperformance in other periods. The high MDD values emphasize the risk.

**2. Recent Stock Price Movement:**

*   **Current Price:** $157.16
*   **Previous Close:** $153.32
*   **Change:** 2.5%
*   **5-day Moving Average:** 153.716
*   **20-day Moving Average:** 154.3045
*   **60-day Moving Average:** 148.5652

**Analysis:** The current price is above the 5-day, 20-day, and 60-day moving averages, suggesting a short-term upward trend.  The recent increase in price relative to the previous close could be a sign of increased volatility due to some issue or news.

**3. Market Risk Indicators and Return Expectations:**

*   **Market Risk Indicator (MRI):** 0.366 (Low Risk)
*   **RSI:** 51.82
*   **PPO:** -0.0937
*   **Hybrid Signal:** cash_70%_Sell 0.2% of holdings (1 shares - Caution - MRI:0.37) (Cash Ratio: 70% on 2025-05-22)
*   **20-day Relative Deviation Change:** +0.4 (Short-term increase)
*   **Expected Return:** 128.1% (Long-term, relative to S&P 500)

**Analysis:**

*   The MRI indicates a low-risk environment.
*   The RSI is near neutral.
*   The PPO is slightly negative.
*   The Hybrid Signal suggests caution. Despite a low MRI, it recommends reducing exposure to 30% and holding 70% in cash. This signal potentially reflects a more nuanced view of risk, considering factors beyond the MRI.
*   Positive Relative Deviation Change: A positive change suggests short-term outperformance relative to its historical deviations.
*   High Expected Return: The expected return is very high, but it's crucial to remember this is a long-term projection and comes with the risks indicated by the historical volatility.

**4. Recent News & Significant Events:**

*   **2025-05-26:** Major business developments, regulatory changes, or market events.
*   **2025-05-27:** Analyst discussions on performance in the context of industry trends and global economics.
*   **2025-05-25:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-05-28:** Market experts highlighting risks and opportunities, advising monitoring of news and announcements.

**Analysis:** The news indicates that Natera is experiencing significant events and volatility, requiring close monitoring. Analyst discussions and expert opinions suggest that there is both opportunity and risk associated with the stock.

**5. Recent Earnings Analysis:**

| 날짜       | EPS    | 매출      |
|------------|--------|-----------|
| 2025-05-09 | -0.5   | 0.50 B$   |
| 2024-11-12 | -0.26  | 0.44 B$   |
| 2024-08-09 | -0.3   | 0.41 B$   |
| 2024-05-10 | -0.56  | 0.37 B$   |
| 2025-05-09 | -0.56  | 0.37 B$   |

**Analysis:**

*   **EPS:** Consistently negative, indicating that the company is not currently profitable.
*   **Revenue:** Trending upward, suggesting growth in the company's top line. The growth in revenue may be a positive sign, but the consistent losses necessitate closer scrutiny of the company's cost structure and path to profitability.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-03-31 | $0.50B    | 63.12%        |
| 2024-12-31 | $0.48B    | 62.94%        |
| 2024-09-30 | $0.44B    | 61.79%        |
| 2024-06-30 | $0.41B    | 58.83%        |
| 2024-03-31 | $0.37B    | 56.72%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE       |
|------------|-----------|-----------|
| 2025-03-31 | $1.24B    | -5.40%    |
| 2024-12-31 | $1.20B    | -4.50%    |
| 2024-09-30 | $0.88B    | -3.60%    |
| 2024-06-30 | $0.84B    | -4.48%    |
| 2024-03-31 | $0.79B    | -8.51%    |

**Analysis:**

*   **Revenue:** Continues to grow, indicating increasing market demand for Natera's products.
*   **Profit Margin:** Increasing, which is a positive sign, but doesn't translate to positive profitability.
*   **Equity:** Increasing, suggesting improved financial stability.
*   **ROE:** Negative, indicating that the company is not generating profits from its equity.

**7. Overall Analysis & Summary:**

Natera (NTRA) presents a complex picture for investors.

*   **Positives:**
    *   Significant historical outperformance relative to the S&P 500 (though currently at the lower end of its historical deviation range).
    *   Increasing revenue and profit margins.
    *   High long-term expected return.
    *   Recent positive stock price movement.
    *   Low Market Risk Indicator (MRI).

*   **Negatives:**
    *   High historical volatility and maximum drawdown.
    *   Consistently negative EPS and ROE, indicating a lack of current profitability.
    *   Hybrid Signal recommending caution and a reduction in holdings.
    *   Recent news highlighting significant events and volatility.

**Conclusion:**

Natera is a high-risk, high-reward stock. The company shows promise with increasing revenue and profit margins, and a high long-term return expectation. However, the consistent losses, high volatility, and cautionary signals require investors to proceed with caution. Close monitoring of news, earnings reports, and analyst opinions is crucial. The recommendation to reduce holdings and hold a high cash position (70%) reflects a cautious approach to managing the risks associated with NTRA.
